A series of steps or a cycle of reactions that could achieve the enrichment of phosphatidylinositol with 1-stearoyl-2-archidonoyl phosphatidylinositol needs to be proposed. Concept Introduction: The phosphatidylinositol cycle involves in cell signaling. Its major purpose is to synthesize phosphatidylinositol and its phosphorylated forms. The lipid intermediate of PI cycle are highly enriched with 1-stearoyl-2-arachidnoyl molecular species. This enrichment is retained as long as the intermediates are segregated from other lipids. What happens in the enrichment of a particular phospholipid molecule is selective addition of one specific type of alkyl or the acyl chain. There are several enzymes that involve in the conversion of phospholipids to exhibit specific acyl or alkyl chains.

Question

When was the dihydropyridine calcium channel blocker isradipine first patented and by whom? Please provide information on the origin and history of isradipine and who owns it/manufactures it.

Answer 1

Question

Chapter 24, Problem 20P

Interpretation Introduction

Interpretation:

A series of steps or a cycle of reactions that could achieve the enrichment of phosphatidylinositol with 1-stearoyl-2-archidonoyl phosphatidylinositol needs to be proposed.

Concept Introduction:

The phosphatidylinositol cycle involves in cell signaling. Its major purpose is to synthesize phosphatidylinositol and its phosphorylated forms. The lipid intermediate of PI cycle are highly enriched with 1-stearoyl-2-arachidnoyl molecular species. This enrichment is retained as long as the intermediates are segregated from other lipids. What happens in the enrichment of a particular phospholipid molecule is selective addition of one specific type of alkyl or the acyl chain. There are several enzymes that involve in the conversion of phospholipids to exhibit specific acyl or alkyl chains.

Expert Solution & Answer

Trending nowThis is a popular solution!

See solution

Check out sample textbook solution

Students have asked these similar questions

When was the dihydropyridine calcium channel blocker isradipine first patented and by whom? Please provide information on the origin and history of isradipine and who owns it/manufactures it.

9) Below, there is a representation of an SDS-PAGE gel. Assuming the samples in the MW standard have masses of: 66 kDa, 45 kDa, 36 kDa, 29 kDa, 24 kDa, 20.1 kDa, and 14.2 kDa, a) Figure 4: indicate where each of the measurements were taken and label as in II.6. figure 2 above. b) As in II.7. Table 1 above create Table 2 using the data below. Determine the r.f. values for the MW standards, plot the relative mobility versus the log of the mass for the standards, and use the best fit straight line to determine the molecular weights of the proteins in the whey, peak 1, and peak 2 lanes. (5 pts—this will be scaled up appropriately if your gel did not develop properly) dye MW Whey Peak 1 Peak 2

what are the different classes and some examples of neuroprotectants that can be used to treat, prevent, or combat neurotoxicity/a neurotoxicant...for example, antioxidants, nutraceuticals, etc.,..?